L. Griffith

发表

Primary Immune Deficiency Treatment Consortium (PIDTC) update.

L. Notarangelo, J. Puck, T. Torgerson, 2016, The Journal of allergy and clinical immunology.

Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases.

S. Heimfeld, K. Sullivan, R. Nash, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Poor T-cell receptor β repertoire diversity early posttransplant for severe combined immunodeficiency predicts failure of immune reconstitution

L. Notarangelo, J. Puck, S. S. De Ravin, 2021, The Journal of allergy and clinical immunology.

Histologically discordant lymphomas with B-cell and T-cell components.

E. Jaffe, M. Raffeld, J. Taubenberger, 1997, American journal of clinical pathology.

Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993–2010): factors that predict intensity and time to transfusion independence

A. Barrett, D. Stroncek, J. Tisdale, 2018, Transfusion.

Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States.

M. Mayes, K. Sullivan, D. Furst, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation.

A. Barrett, D. Stroncek, R. Childs, 2001, Blood.

Excellent Outcomes Following Hematopoietic Cell Transplantation for Wiskott-Aldrich Syndrome: A PIDTC Report.

L. Notarangelo, H. Ochs, J. Puck, 2020, Blood.

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report.

D. Arnold, G. Kraft, J. Bowen, 2015, JAMA neurology.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

J. Wingard, J. Gea-Banacloche, S. Paczesny, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Primary Immune Deficiency Treatment Consortium (PIDTC) report.

M. van der Burg, L. Notarangelo, H. Bobby Gaspar, 2014, The Journal of allergy and clinical immunology.

Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management.

L. Notarangelo, H. Ochs, J. Puck, 2009, The Journal of allergy and clinical immunology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.

Shannon R. McCurdy, R. Jenq, G. Cuvelier, 2021, Transplantation and cellular therapy.

Granulocyte Transfusions in Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Cell Transplantation or Gene Therapy

L. Notarangelo, J. Puck, T. Torgerson, 2022, Journal of Clinical Immunology.

Adenocarcinoid tumor of the periampullary region: a novel duodenal neoplasm presenting as biliary tract obstruction.

A. West, M. Jones, L. Griffith, 1989, Human pathology.

Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience.

L. Notarangelo, J. Puck, S. Pai, 2014, The Journal of allergy and clinical immunology.

Myeloablative Autologous Stem‐Cell Transplantation for Severe Scleroderma

M. Mayes, S. Heimfeld, K. Sullivan, 2018, The New England journal of medicine.

Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.

L. Notarangelo, J. Puck, K. Sullivan, 2017, Blood.

Outcomes Following Treatment for Adenosine Deaminase Deficient Severe Combined Immunodeficiency: A Report from the PIDTC.

L. Notarangelo, J. Puck, T. Torgerson, 2022, Blood.

SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.

L. Notarangelo, J. Puck, K. Sullivan, 2018, Blood.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.

D. Miklos, J. Pidala, E. Russek-Cohen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation.

L. Notarangelo, J. Walter, J. Puck, 2018, Blood.

The Natural History of Children with Severe Combined Immunodeficiency: Baseline Features of the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium Prospective Study 6901

L. Notarangelo, J. Puck, S. Pai, 2013, Journal of Clinical Immunology.

Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs.

L. Notarangelo, J. Puck, K. Sullivan, 2008, The Journal of allergy and clinical immunology.

Persistence of recipient plasma cells and anti‐donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non‐myeloablative haematopoietic cell transplantation

J. P. McCoy, R. Srinivasan, J. McCoy, 2005, British journal of haematology.

Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005.

M. Mayes, B. Sandmaier, Roland Martin, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors.

N. Geller, W. Linehan, R. Srinivasan, 2004, Blood.

Transplantation outcomes for severe combined immunodeficiency, 2000-2009.

L. Notarangelo, J. Puck, K. Sullivan, 2014, The New England journal of medicine.

Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey

L. Notarangelo, J. Walter, J. Puck, 2020, Frontiers in Immunology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report.

M. Mohty, Stephanie J. Lee, S. Pavletic, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment of immunodeficiency: long-term outcome and quality of life.

L. Notarangelo, W. Shearer, L. Griffith, 2008, The Journal of allergy and clinical immunology.

Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT

L. Notarangelo, J. Puck, T. Torgerson, 2019, Journal of Clinical Immunology.

The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions

L. Notarangelo, J. Puck, K. Sullivan, 2022, The Journal of allergy and clinical immunology.

The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions

L. Notarangelo, J. Puck, S. Pai, 2022, The Journal of allergy and clinical immunology.

Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers

L. Notarangelo, J. Puck, T. Torgerson, 2020, Journal of Clinical Immunology.

Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers

L. Notarangelo, J. Puck, T. Torgerson, 2020, Journal of Clinical Immunology.

Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Ped

L. Notarangelo, J. Puck, A. Gennery, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Survey on retransplantation criteria for patients with severe combined immunodeficiency.

L. Notarangelo, E. Haddad, M. Cowan, 2014, The Journal of allergy and clinical immunology.

Survey on Re-transplantation Criteria for Severe Combined Immunodeficiency Patients Allergy Clin Immunol .

L. Notarangelo, Elie Haddad, Cowan, 2014 .

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS

D. Arnold, G. Kraft, J. Bowen, 2017, Neurology.

T cell repertoire following autologous stem cell transplantation for multiple sclerosis.

C. Desmarais, H. Robins, L. Turka, 2014, The Journal of clinical investigation.

Sex cord tumor with annular tubules associated with endometriosis of the fallopian tube.

M. Carcangiu, L. Griffith, 1991, American journal of clinical pathology.

Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials.

Stephanie J. Lee, Paul J. Martin, L. M. Griffith, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.

H. Atkins, K. Sullivan, M. Pasquini, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies.

D. Arnold, H. Atkins, G. Kraft, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Resolution of CGD Related Colitis after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Granulomatous Disease—Early Results From the 6903 Study of the Primary Immune Deficiency Treatment Consortium (PIDTC)

L. Notarangelo, J. Puck, K. Sullivan, 2018 .

Glycogenosis type II: A juvenile‐specific mutation with an unusual splicing pattern and a shared mutation in African Americans

N. Raben, P. Plotz, J. Becker, 1997, Human mutation.

Target populations in allogeneic hematopoietic cell transplantation for autoimmune diseases--a workshop accompanying: cellular therapy for treatment of autoimmune diseases, basic science and clinical studies, including new developments in hematopoietic and mesenchymal stem cell therapy.

D. Furst, A. Gratwohl, A. Tyndall, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018).

L. Notarangelo, J. Puck, T. Torgerson, 2019, The Journal of allergy and clinical immunology.

Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation.

Jeffrey A. Cohen, H. Atkins, K. Sullivan, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Natural History of Children with Severe Combined Immunodeficiency Disease (SCID): The First Fifty Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901

L. Notarangelo, J. Puck, D. Kohn, 2013 .

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

Jeffrey A. Cohen, Deborah M. Miller, D. Arnold, 2020 .

Extensive intrathecal T cell renewal following hematopoietic transplantation for multiple sclerosis.

P. Lindau, H. Robins, L. Turka, 2019, JCI insight.

Autologous HSCT for advanced MS: is the glass half-empty or really half-full?

G. Kraft, J. Bowen, E. Frohman, 2008, Brain : a journal of neurology.

Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901

L. Notarangelo, J. Puck, K. Sullivan, 2015 .

Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium

L. Notarangelo, J. Puck, T. Torgerson, 2023, The Lancet.